T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates
- PMID: 7595211
- PMCID: PMC2192223
- DOI: 10.1084/jem.182.5.1403
T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates
Abstract
Peptides from the lumenal portion of invariant chain (Ii) spanning residues 80-106 (class II-associated Ii peptide [CLIP]) are found in association with several mouse and human major histocompatibility complex (MHC) class II allelic variants in wild-type and presentation-deficient mutant cells. The ready detection of these complexes suggests that such an intermediate is essential to the MHC class II processing pathway. In this study, we demonstrate that T cells recognize CLIP/MHC class II complexes on the surface of normal and mutant cells in a manner indistinguishable from that of nominal antigenic peptides. Surprisingly, T cell hybrids specific for human CLIP bound to murine MHC class II molecule I-Ab and a new monoclonal antibody 30-2 with the same specificity, recognize two independent epitopes expressed on this peptide/class II complex. T cell recognition is dependent on a Gln residue (position 100) in CLIP, whereas the 30-2 antibody recognizes a Lys residue-at position 90. These two residues flank the 91-99 sequence that is conserved among human, mouse, and rat Ii, potentially representing an MHC class II-binding site. Our results suggest that the COOH-terminal portion of CLIP that includes TCR contact residue Gln 100 binds in the groove of I-Ab molecule. Moreover, both T cells and the antibody recognize I-Ab complexed with larger Ii processing intermediates such as the approximately 12-kD small leupeptin-induced protein (SLIP) fragments. Thus, SLIP fragments contain a CLIP region bound to MHC class II molecule in a conformation identical to that of a free CLIP peptide. Finally, our data suggest that SLIP/MHC class II complexes are precursors of CLIP/MHC class II complexes.
Similar articles
-
A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.Eur J Immunol. 1996 Feb;26(2):385-93. doi: 10.1002/eji.1830260218. Eur J Immunol. 1996. PMID: 8617308
-
Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.Eur J Immunol. 2002 Sep;32(9):2510-20. doi: 10.1002/1521-4141(200209)32:9<2510::AID-IMMU2510>3.0.CO;2-Q. Eur J Immunol. 2002. PMID: 12207335
-
T cell recognition of flanking residues of murine invariant chain-derived CLIP peptide bound to MHC class II.Cell Immunol. 1998 Aug 25;188(1):49-54. doi: 10.1006/cimm.1998.1347. Cell Immunol. 1998. PMID: 9743557
-
Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.Immunol Rev. 2005 Oct;207:242-60. doi: 10.1111/j.0105-2896.2005.00306.x. Immunol Rev. 2005. PMID: 16181341 Review.
-
Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.Immunogenetics. 2019 Mar;71(3):233-249. doi: 10.1007/s00251-018-1090-2. Epub 2018 Oct 30. Immunogenetics. 2019. PMID: 30377750 Review.
Cited by
-
TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review.Front Immunol. 2022 Jul 27;13:968432. doi: 10.3389/fimmu.2022.968432. eCollection 2022. Front Immunol. 2022. PMID: 35967436 Free PMC article. Review.
-
Reduction of myeloid-derived suppressor cells and lymphoma growth by a natural triterpenoid.J Cell Biochem. 2015 Jan;116(1):102-14. doi: 10.1002/jcb.24946. J Cell Biochem. 2015. PMID: 25142864 Free PMC article.
-
Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein.Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13856-61. doi: 10.1073/pnas.94.25.13856. Proc Natl Acad Sci U S A. 1997. PMID: 9391117 Free PMC article.
-
Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA)-DR2-MBP 85-99 complex.J Exp Med. 2000 Apr 17;191(8):1395-412. doi: 10.1084/jem.191.8.1395. J Exp Med. 2000. PMID: 10770805 Free PMC article.
-
GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity.Eur J Immunol. 2013 Jan;43(1):65-74. doi: 10.1002/eji.201242379. Epub 2012 Nov 26. Eur J Immunol. 2013. PMID: 23012103 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials